32939-32-5

Basic information

• Product Name: (3-pyridyl)-methyl-4-nitrophenyl-carbonate
• Synonyms: (3-pyridyl)-methyl-4-nitrophenyl-carbonate
• CAS NO: 32939-32-5
• Molecular Weight: 274.233
• Mol File: 32939-32-5.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: (3-pyridyl)-methyl-4-nitrophenyl-carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: (3-pyridyl)-methyl-4-nitrophenyl-carbonate(32939-32-5)
• EPA Substance Registry System: (3-pyridyl)-methyl-4-nitrophenyl-carbonate(32939-32-5)

Safety Data

• Hazardous Substances Data: 32939-32-5(Hazardous Substances Data)

Upstream product

• 7693-46-1 4-Nitrophenyl chloroformate 
• 100-55-0 3-hydroxymethylpyridin 
• 81420-42-0 mononitrophenyl carbonate 
• 109-02-4 4-methyl-morpholine 
• 5070-13-3 bis-(p-nitrophenyl) carbonate 

Downstream Products

• 1383570-17-9 pyridin-3-ylmethyl [(2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl]carbamate 
• 1391621-77-4 C₂₈H₃₃N₉O₃ 
• 1391621-74-1 C₂₇H₃₁N₉O₂ 
• 1391621-68-3 C₃₀H₃₂N₆O₅ 
• 1391621-67-2 3-pyridylmethyl-N-[4-(5-[4-(2-(tetrahydro-1H-1-pyrrolyl)ethoxy)benzoyl]amino-1H-3-pyrazolyl)benzyl]carbamate 
• 1391621-66-1 3-pyridylmethyl-N-[4-(5-[4-(4-methylpiperazino)benzoyl]amino-1H-3-pyrazolyl)benzyl]carbamate 
• 262444-13-3 3-pyridylmethyl N-[4-(4-amino-7-tetrahydro-2H-4-pyranyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methoxyphenyl]carbamate 
• 262433-21-6 3-Pyridylmethyl N-(4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methoxyphenyl)carbamate 

Relevant articles and documents

Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir

Utilization of the cytochrome P450 3A4 (CYP3A4) inhibitor ritonavir as a pharmacoenhancer for anti-HIV drugs revolutionized the treatment of HIV infection. However, owing to ritonavir-related complications, there is a need for development of new CYP3A4 in

2, 6 BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS

4-Aminopyrimidine derivatives of formula (I) FORMULA heteroaryl groups, including pharmaceutically acceptable salts thereof, wherein R1 and R2 are adenosine A2A receptor antagonists useful in the treatment of movement disorders such as Parkinson's disease.

Pyrrolopyrimidines as therapeutic agents

Chemical compounds having structural formula I and physiologically acceptable salts and metabolites thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases, whose activity is inhibited by these chemical compounds, are involved in immunologic, hyperproliferative, or angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyper proliferative disorders, rheumatiod arthritis, disorders of the immune system, trasplant refections and imflammatory disorders.